Correlation Analysis
Johnson & Johnson vs UL Solutions Inc.
JNJ vs ULS
+0.751
Strong positive
When one moves up, the other tends to follow.
Johnson & Johnson
↗JNJ
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Market cap 580.4B
UL Solutions Inc.
↗ULS
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
Market cap 16.9B · 14,851 employees
Time Series
Relative Performance
Who Moves First
ULS leads JNJ by 2 days
ULS tends to move before JNJ.
After testing 13 timing shifts, the strongest relationship was +0.751 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.064
16 periods · Return correlation when both series rose
Both Falling
+0.688
6 periods · Return correlation when both series fell
Diverging
-0.611
13 periods · Return correlation when series moved apart
R-Squared
56.4%
Share of variance in one series explained by the other.
Trend Agreement
50.8%
How often both series moved in the same direction period-to-period.
Overlap Quality
497
Robust shared window — 497 usable pairs.
Significance
p < 0.001
95% CI: [0.710, 0.787]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
497 paired data points survived the daily window.
Raw input
1,254
497
Normalized
1,254
497
Prepared
1,254
497
Aligned
497
497
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
757
A: 757 / B: 0
Series A
Johnson & Johnson
JNJ
Market cap 580.4B
Stock · 1,254 raw → 1,254 prepared
Series B
UL Solutions Inc.
ULS
Market cap 16.9B · 14,851 employees
Stock · 497 raw → 497 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
30
Estimated crossover points between normalized spreads.
Slope
0.3824
Linear regression slope.
Intercept
-4.9249
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-jnj-vs-stock-uls-daily